Lubricin is a synovial glycoprotein that contributes to joint lubrication. We propose the hypothesis that lubricin is a key modulator of the psychoneuroendocrine-osteoimmune interactome, with important clinical relevance for osteoarthritic pathologies. We consider a variety of neuroendocrine-immune factors, including inflammatory cytokines and chemokines that may contribute to the modulation of lubricin in rheumatic complications. Based on our preliminary immunocytochemistry and fractal analysis data, and in the context of translational research of modern healthcare, we propose that molecular lubricin gene expression modification by means of the novel CRISPR/Cas system be considered for osteoarthritic therapies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680716PMC
http://dx.doi.org/10.6026/97320630013343DOI Listing

Publication Analysis

Top Keywords

osteoarthritic pathologies
8
lubricin
5
lubricin principal
4
principal modulator
4
modulator psychoneuroendocrine
4
psychoneuroendocrine osteoimmune
4
osteoimmune interactome
4
interactome implications
4
implications novel
4
novel treatments
4

Similar Publications

Harnessing Raman spectroscopy and multimodal imaging of cartilage for osteoarthritis diagnosis.

Sci Rep

December 2024

School of Chemistry, Faculty of Engineering and Physical Sciences, University of Southampton, Life Sciences Building 85, University Road, Highfield, Southampton, SO17 1BJ, UK.

Osteoarthritis (OA) is a complex disease of cartilage characterised by joint pain, functional limitation, and reduced quality of life with affected joint movement leading to pain and limited mobility. Current methods to diagnose OA are predominantly limited to X-ray, MRI and invasive joint fluid analysis, all of which lack chemical or molecular specificity and are limited to detection of the disease at later stages. A rapid minimally invasive and non-destructive approach to disease diagnosis is a critical unmet need.

View Article and Find Full Text PDF

Osteoarthritis (OA) is a prevalen degenerative joint disease with no FDA-approved therapies that can halt or reverse its progression. Current treatments address symptoms like pain and inflammation, but not underlying disease mechanisms. OA progression is marked by increased inflammation and extracellular matrix (ECM) degradation of the joint cartilage.

View Article and Find Full Text PDF

Background: Osteoarthritis (OA) is a painful degenerative joint disease and a leading source of years lived with disability globally due to inadequate treatment options. Neuroimmune interactions reportedly contribute to OA pain pathogenesis. Notably, in rodents, macrophages in the DRG are associated with onset of persistent OA pain.

View Article and Find Full Text PDF

Objective: This study aimed to explore the repair effect of siRNA-mediated double silencing of the mechanically sensitive ion channels Piezo1 and TRPV4 proteins on a rat model of osteoarthritis.

Methods: Piezo1 and TRPV4 interference plasmids were constructed using siRNA technology. Sprague Dawley (SD) rats were divided into four groups: the model group, siRNA-Piezo1, siRNA-TRPV4, and double gene silencing groups.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the osteochondral interface, which includes calcified cartilage (CC) and subchondral bone (SCB), and presents a new method for analyzing chondrocyte and osteocyte lacunae in human knee samples using advanced imaging techniques.
  • Researchers employed a combination of a marker-controlled watershed algorithm and deep learning (specifically nnU-Net) to enhance the 3D segmentation of cell lacunae, effectively improving the assessment of their structures.
  • Findings showed that while chondrocyte characteristics didn't differ significantly between control and osteoarthritic knees, osteocytes in the osteoarthritic group exhibited lower anisotropy and tended to be more spherical,
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!